Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00212407 · ClinicalTrials.gov registry record · Early Phase 1
New York Blood Center National Cord Blood Program
A Early Phase 1 study, sponsored by New York Blood Center.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 4,476
- Enrollment target
NCT00212407: Clinical Trial Early Phase 1 study, sponsored by New York Blood Center.
NCT00212407 is a Early Phase 1 study that was terminated before completion, run by New York Blood Center. The registered enrollment target is 4,476 participants, above the 52-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (8508% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00212407, a Early Phase 1 study, was terminated before completion, sponsored by New York Blood Center.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 4,476 participants
- Enrollment target
Study Summary
Umbilical cord blood is used as a source of hematopoietic stem cells for bone marrow reconstitution in patients who would be potential candidates for a bone marrow transplant from an unrelated marrow donor. The outcome of transplantation is obtained to assess cord blood myeloid and platelet engraftment, transplant related mortality, overall survival, graft vs. host disease and, for patients with leukemia, lymphoma or myelodysplasia, relapse.
Interventions
- BIOLOGICAL Umbilical Cord Blood Transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,476 participants |
| Start Date | 1993-02 |
| Est. Completion | 2011-11-10 |
| Phase | Early Phase 1 |
Why NCT00212407 stopped before completion
NCT00212407 is an interventional study that assigns participants to a tested intervention. Its 4,476 participants enrollment target places it among the larger protocols in the corpus, above the 52-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (8508% higher).
The record links to 0 conditions, and to 1 intervention - of which Umbilical Cord Blood Transplantation is the first listed.
NCT00212407 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00212407 about?
NCT00212407 is a clinical study titled "New York Blood Center National Cord Blood Program". Umbilical cord blood is used as a source of hematopoietic stem cells for bone marrow reconstitution in patients who would be potential candidates for a bone marrow transplant from an unrelated marrow donor. The outcome of transplantation is obtained to assess cord blood myeloid and platelet engraftm...
What is the current status of trial NCT00212407?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 4,476 participants. The study started on 1993-02. Estimated completion is 2011-11-10.
What interventions are being tested in trial NCT00212407?
The interventions under investigation include: Umbilical Cord Blood Transplantation (BIOLOGICAL).
Who is sponsoring clinical trial NCT00212407?
This trial is sponsored by New York Blood Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00212407's enrollment target sits among peer trials
4,476 2nd of 2000 the highest of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06252753 · 4,490 participants
Observational Study Protocol: LIVER-R
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
- NCT06588452 · 4,500 participants
Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models
- NCT07165028 · 4,500 participants · Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia